Activity ID



August 23, 2020

Format Type


CME Credit



CME Provider

American Society for Clinical Oncology


The 2017 Annual Meeting Highlights Radiation Oncology is designed to help the busy radiation oncologist remain abreast of key scientific updates and cancer care strategies that relate to practice from the 2017 ASCO Annual Meeting. This expert-led course provides a comprehensive collection on an array of key topics from the 2017 Annual Meeting relevant to the radiation oncologist. In addition, this course may also benefit medical oncologists, fellows, and advanced practice providers.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

Breast Cancer
Review the new margin guidelines on patterns of care
Identify if new-adjuvant chemotherapy changes lumpectomy rates for TNBC
Gynecologic Cancer
Review advances in adjunct chemotherapy and radiation therapy versus radiation therapy alone for high risk endometrial cancer
Explain the role cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel for locally advanced endometrial carcinoma
Central Nervous System Tumors
Describe the role of radiation in altering the blood brain barrier for systemic agents
Explain the hrole of bevacizumab in combination with radiation in newly diagnosed GBM
Describe the impact of bevacizumab on elderly patients with diagnosed GBM
Gastrointestinal (Non-Colorectal) Cancer
Describe the role od adjuvant therapy in biliary tract cancers
Evaluate the role of surgery for esophageal squamous cell carcinoma after chemoradiation
Determine the impact of radioembolization for intermediate and advanced stage hepatocellular carcinoma
Gastrointestinal (colorectal) Cancer
Describe the setting when 3 months of adjuvant oxaliplatin-based chemotherapy for Stage III Colon Cancer is non-inferior to 6 months
Describe the impact of total neoadjuvant therapy (TNT) on the delivery of chemotherapy and pathologic complete response in locally advanced rectal cancer
Explain the impact of selective internal radiotherapy (SIRT) using yttrium-90 resin microspheres on overall survival, response rate, and acute toxicity in patients with liver metastases receiving systemic chemothrapy
Geitourinary (Prostate) Cancer
Assess the data on optimal duration of androgen deprivation therapy when used in conjunction with external beam dose radiation for high risk prostate cancer
Determine if PD-1 inhibitors can be safely administered in an adjuvant setting after chemoradiation for stage III NSCLC with curative intent
Determine the more optimal dose of external beam radiation given to LS-SCLC patients treated once daily, 60 Gy vs 70Gy or higher
Describe what are the outcomes of melanoma patients with brain metastases treated with initial systemic therapy including checkpoint inhibitors or BRAF/MEK inhibitors
Explain the effects of radionecrosis following brain radiation and checkpoint inhibitor administration
Head and Neck Cancer
Explain the impact of treating weekly vs bolus cisplatin in the post-operative and definitive treatment settings
Discuss when the use of induction chemotherapy in nasopharynx cancer patients is beneficial
Determine when is the appropriate time to treat cutaneous squamous cell carcinoma patients with post-op radiation therapy (RT) with or without chemotherapy


Radiation oncology; treatment radiation; management of radiation; radiation techniques, radiotherapy


Interpersonal & Communication Skills, Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Inpatient, Outpatient, VA/Military

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.